Moreover, in vivo CRISPR-engineered animal models, including mice carrying humanized RBCs or specific allelic variants such as PIEZO1 gain-of-function mutations-have provided critical insights into the role of host genes in modulating vascular pathology and cerebral malaria outcomes [219]. The gene discussed is PIEZO1; the disease is cerebral malaria.